Free Trial

Bicara Therapeutics (BCAX) SEC Filings & 10K Form

Bicara Therapeutics logo
$24.01
+0.33 (+1.39%)
(As of 11/1/2024 ET)

Recent Bicara Therapeutics SEC Filings

DateFilerForm TypeView
09/26/2024
3:30 PM
Bicara Therapeutics (Subject)
Invus Global Management, LLC (Filed by)
Form SC 13G
09/26/2024
3:16 PM
Bicara Therapeutics (Subject)
Red Tree GP, LLC (Filed by)
Form SC 13G
09/23/2024
3:17 PM
Bicara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D
09/18/2024
5:02 PM
Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
4:02 PM
Bicara Therapeutics (Issuer)
BONDERMAN DAVID (Reporting)
COULTER JAMES G (Reporting)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
4:10 PM
Bicara Therapeutics (Subject)
TPG GP A, LLC (Filed by)
Form SC 13D
09/18/2024
10:54 AM
Bicara Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
10:54 AM
Bicara Therapeutics (Issuer)
FIL Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
10:57 AM
Bicara Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
09/17/2024
5:16 PM
Bicara Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
Deerfield Mgmt V, L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund V, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:49 PM
Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:35 PM
Bicara Therapeutics (Issuer)
Mazumdar-Shaw Kiran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:35 PM
Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:38 PM
Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:39 PM
Bicara Therapeutics (Issuer)
Biocon Ltd (Reporting)
Biocon Pharma Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:41 PM
Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:42 PM
Bicara Therapeutics (Issuer)
LONBERG NILS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:45 PM
Bicara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/12/2024
11:15 PM
Bicara Therapeutics (Filer)
Form EFFECT
09/12/2024
8:19 PM
Bicara Therapeutics (Issuer)
Hyep Ivan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:20 PM
Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:24 PM
Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:27 PM
Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
7:58 PM
Bicara Therapeutics (Issuer)
FIL Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:00 PM
Bicara Therapeutics (Issuer)
FMR LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:00 PM
Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:00 PM
Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:00 PM
Bicara Therapeutics (Issuer)
Biocon Ltd (Reporting)
Biocon Pharma Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:01 PM
Bicara Therapeutics (Issuer)
NG CAROLYN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:03 PM
Bicara Therapeutics (Issuer)
LONBERG NILS (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:07 PM
Bicara Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
Deerfield Mgmt V, L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund V, L.P. (Reporting)
Flynn James E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:07 PM
Bicara Therapeutics (Issuer)
Cohlhepp Ryan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:09 PM
Bicara Therapeutics (Issuer)
Mazumdar Claire (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:11 PM
Bicara Therapeutics (Issuer)
Bowden Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:11 PM
Bicara Therapeutics (Issuer)
Mazumdar-Shaw Kiran (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:15 PM
Bicara Therapeutics (Issuer)
Raben David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
8:16 PM
Bicara Therapeutics (Issuer)
POWELL MICHAEL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
7:48 PM
Bicara Therapeutics (Issuer)
BONDERMAN DAVID (Reporting)
COULTER JAMES G (Reporting)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:37 PM
Bicara Therapeutics (Filer)
Form S-1MEF
09/12/2024
12:07 PM
Bicara Therapeutics (Filer)
Form CERT
09/11/2024
3:23 PM
Bicara Therapeutics (Filer)
Form S-1/A
Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).
09/10/2024
3:06 PM
Bicara Therapeutics (Filer)
Form 8-A12B
09/06/2024
5:31 AM
Bicara Therapeutics (Filer)
Form S-1/A
09/03/2024
6:26 AM
Bicara Therapeutics (Filer)
Form S-1/A
08/22/2024
3:38 PM
Bicara Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCAX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners